New research identifies a brain circuit where serotonin directly influences tinnitus-like behaviors
A study published in April 2026 in the Proceedings of the National Academy of Sciences shows that elevated serotonin levels can heighten tinnitus symptoms through a targeted pathway in the brain. Researchers at Oregon Health & Science University and Anhui University in China used a mouse model to map how the neurotransmitter activates neurons in the dorsal cochlear nucleus, producing behaviors consistent with the phantom sounds people experience as ringing or buzzing.
Tinnitus affects up to 14 percent of adults worldwide. For many, the condition remains a constant background noise; for others, it triggers significant distress, sleep disruption, and anxiety. The new findings add a layer of detail to earlier observations that serotonin signaling plays a role in auditory processing.
Mouse experiments reveal precise mechanism
The team focused on the dorsal raphe nucleus, a serotonin-producing region, and its projections to the dorsal cochlear nucleus, an early station in the auditory pathway. Using optogenetic tools, they selectively activated serotonergic neurons and recorded both neural activity and behavioral responses. Mice showed increased startle reflexes to sound gaps, a standard proxy for tinnitus perception in animal models.
When the researchers blocked specific serotonin receptors or silenced the circuit, the tinnitus-like behaviors diminished. The work builds on a 2017 study from the same groups that first linked serotonin to hyperactivity in the same brain area. The 2026 paper provides a clearer map of the discrete circuit involved.
Co-senior author Laurence Trussell of OHSU noted that stimulating the pathway produced activity patterns and behaviors matching what would be expected if the animals perceived tinnitus. The findings align with patient reports of worsened symptoms shortly after starting medications that raise serotonin levels.
Context on serotonin and auditory processing
Serotonin, also known as 5-hydroxytryptamine or 5-HT, acts as a chemical messenger across many brain systems. It helps regulate mood, sleep, and appetite. In the auditory system, its effects appear more selective than previously assumed. The new data indicate it can suppress some sound-processing routes while amplifying others, particularly multisensory inputs that feed into the dorsal cochlear nucleus.
This pathway-specific action helps explain why global increases in serotonin, such as those produced by selective serotonin reuptake inhibitors, sometimes coincide with changes in tinnitus perception. Earlier clinical studies produced mixed results: some patients reported relief when SSRIs eased accompanying depression or anxiety, while others noted increased ringing.
Implications for people taking SSRIs
Selective serotonin reuptake inhibitors remain first-line treatments for moderate to severe depression and anxiety. The study does not recommend stopping these medications. Instead, it underscores the need for individualized prescribing when tinnitus is already present.
Trussell advised patients to discuss any perceived changes in tinnitus with their physician. Clinicians can monitor symptoms closely and consider dose adjustments, slower titration, or alternative therapies if side effects emerge. Abrupt discontinuation of SSRIs carries its own risks and should never occur without medical guidance.
Experts interviewed by Medical News Today emphasized that the mouse data represent an early mechanistic insight rather than a direct clinical directive. Adverse reactions to SSRIs involving tinnitus appear uncommon in practice, affecting a small minority of patients. Psychological factors such as anxiety and depression themselves can intensify tinnitus distress, complicating direct attribution to medication.
Photo by Robina Weermeijer on Unsplash
Broader patient considerations and next steps
Anyone experiencing both mental health symptoms and tinnitus benefits from coordinated care between psychiatry and audiology or otolaryngology. Cognitive behavioral therapy, sound therapy, and sleep hygiene measures often form part of management plans alongside or instead of medication adjustments.
Further human studies will be required to determine whether the circuit identified in mice operates similarly in people and whether receptor-specific drugs could separate antidepressant benefits from auditory side effects. The current work points toward the possibility of more targeted interventions that modulate serotonin in selected brain regions.
Public health estimates place tinnitus prevalence at roughly one in seven adults. As awareness grows, more people are seeking information on how common medications intersect with the condition. The 2026 study supplies one piece of that puzzle while reinforcing the value of open communication between patients and prescribers.
Additional coverage appears in reports from OHSU News and Medical News Today. The full paper is available at PNAS.